Get the Stockscreener App
4.73
7.62%
-0.39
After Hours:
4.96
0.23
+4.86%
Applied Dna Sciences Inc stock is traded at $4.73, with a volume of 142.74K.
It is down -7.62% in the last 24 hours and down -52.94% over the past month.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
See More
Previous Close:
$5.12
Open:
$4.8
24h Volume:
142.74K
Relative Volume:
1.23
Market Cap:
$2.42M
Revenue:
$9.00M
Net Income/Loss:
$-7.21M
P/E Ratio:
-8.60
EPS:
-0.55
Net Cash Flow:
$-7.59M
1W Performance:
+1.28%
1M Performance:
-52.94%
6M Performance:
-97.26%
1Y Performance:
-98.63%
1-Day Range:
$4.40
$5.30
1-Week Range:
$4.40
$5.3799
52-Week Range:
$4.365
$2,655.00
Applied Dna Sciences Inc Stock (APDN) Company Profile
Name
Applied Dna Sciences Inc
Sector
Industry
Phone
631-240-8800
Address
50 HEALTH SCIENCES DRIVE, STONY BROOK, NY
Compare APDN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APDN
Applied Dna Sciences Inc
|
4.73 | 2.42M | 9.00M | -7.21M | -7.59M | -0.55 |
|
TMO
Thermo Fisher Scientific Inc
|
390.26 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
|
DHR
Danaher Corp
|
195.75 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
|
IDXX
Idexx Laboratories Inc
|
520.59 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
116.09 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
154.10 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
Applied Dna Sciences Inc Stock (APDN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-12-21 | Initiated | ROTH Capital | Buy |
| Jan-14-21 | Reiterated | H.C. Wainwright | Buy |
| Dec-18-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-20-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-02-20 | Initiated | H.C. Wainwright | Buy |
| Nov-14-16 | Reiterated | Maxim Group | Buy |
| May-13-16 | Reiterated | Maxim Group | Buy |
| Oct-08-15 | Reiterated | Maxim Group | Buy |
| May-26-15 | Initiated | The Benchmark Company | Speculative Buy |
| Feb-10-15 | Reiterated | Maxim Group | Buy |
| Jan-13-15 | Initiated | Maxim Group | Buy |
View All
Applied Dna Sciences Inc Stock (APDN) Latest News
Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward - Reno Gazette Journal
Applied DNA Sciences names Judy Murrah as new chairperson and CEO - Investing.com India
Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward | APDN Stock News - GuruFocus
APDN Leadership Transition: Judy Murrah Appointed CEO | APDN Sto - GuruFocus
Applied DNA Sciences Appoints Harvard MBA Veteran Judy Murrah as CEO, Founder Retires After Two Decades - Stock Titan
Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August - Knoxville News Sentinel
Applied DNA Sciences (APDN) to Restart Quarterly Investor Calls | APDN Stock News - GuruFocus
Applied DNA to Resume Quarterly Investor Call Cadence Beginning with FQ3'25 Financial Results Report in Mid-August | APDN Stock News - GuruFocus
Applied DNA Sciences Returns to Regular Earnings Updates: What Investors Should Know About New Schedule - Stock Titan
Applied DNA Reports Second Quarter Fiscal 2025 Financial Results - Knoxville News Sentinel
Applied DNA Sciences, Inc. (NASDAQ:APDN) Q3 2024 Earnings Call Transcript - MSN
Applied DNA Sciences fails to secure shareholder vote - MSN
applied dna sciences faces nasdaq delisting due to bid price rule - Investing.com
Applied DNA Sciences Faces Nasdaq Delisting Hearing - TipRanks
Top Premarket Gainers - marketscreener.com
Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17 - Livingston Daily
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025 - Knoxville News Sentinel
Upcoming Stock Splits This Week (June 2 to June 6) – Stay Invested - The Globe and Mail
Applied DNA Sciences, Inc. (NASDAQ:APDN) Short Interest Update - Defense World
APDN stock plunges to 52-week low of $0.32 amid market challenges By Investing.com - Investing.com South Africa
APDN Trading Halted as Market Awaits Significant Announcement | APDN Stock News - GuruFocus
APDN stock plunges to 52-week low of $0.32 amid market challenges - Investing.com Nigeria
Applied DNA announces 1-for-15 reverse stock split - MSN
Applied DNA Reschedules Intra-Quarter Webcast and Investor Update Call to June 17 | APDN Stock News - GuruFocus
Applied DNA Sets Reverse Stock Split for June 2, Moves Key Investor Call to June 17 - Stock Titan
Applied DNA Sciences (APDN) to Implement 1-for-15 Reverse Stock - GuruFocus
Applied DNA Sciences Approves Reverse Stock Split - TipRanks
Applied DNA Announces 1-For-15 Reverse Stock Split Effective June 2, 2025 | APDN Stock News - GuruFocus
Applied DNA Sciences Announces Major 1:15 Reverse SplitShares Drop from 7.8M to 519K in Nasdaq Bid - Stock Titan
Applied DNA Sciences (NASDAQ:APDN) Stock Rating Lowered by Wall Street Zen - Defense World
Applied DNA Sciences Holds Annual Stockholder Meeting - TipRanks
Applied Dna Sciences Inc Stock (APDN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):